Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome
- PMID: 17729408
- PMCID: PMC4611829
- DOI: 10.3748/wjg.v13.i34.4574
Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome
Abstract
Aim: To evaluate whether a higher prevalence of Giardia lamblia infection is associated with an increase in irritable bowel syndrome (IBS) prescriptions at the county level in Michigan.
Methods: The Michigan Disease Surveillance System (MDSS) was used to ascertain both the numbers of Giardia lamblia infections as well as the total number of foodborne illnesses per population by county in Michigan during 2005. This was compared with Blue Cross Blue Shield (BCBS) of Michigan numbers of drug prescriptions for IBS per one thousand members per county in 2005. These data were also analyzed for associations with per capita income by county and the number of refugees entering each county in 2005.
Results: There were a total of 786 confirmed cases of Giardia lamblia reported to MDSS in 2005. During the same time period, the number of prescriptions for IBS varied from 0.5 per 1000 members up to 6.0 per 1000 members per month. There was no trend towards higher numbers of IBS prescriptions in the counties with more Giardia lamblia infections. Per capita income was not associated with either IBS prescriptions or Giardiasis. There was a significant linear association between the number of refugees entering each county, and the number of Giardia lamblia cases per 100,000 population.
Conclusion: In this ecological study, there was no association found between BCBS prescriptions for IBS and Giardia lamblia infections in Michigan counties. Our findings may have been influenced by the disparate number of refugees admitted per county.
Figures





Similar articles
-
The neglected role of Blastocystis sp. and Giardia lamblia in development of irritable bowel syndrome: A systematic review and meta-analysis.Microb Pathog. 2022 Jan;162:105215. doi: 10.1016/j.micpath.2021.105215. Epub 2021 Sep 27. Microb Pathog. 2022. PMID: 34592369
-
Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study.World J Gastroenterol. 2006 Mar 28;12(12):1941-4. doi: 10.3748/wjg.v12.i12.1941. World J Gastroenterol. 2006. PMID: 16610003 Free PMC article.
-
Prevalence of fibromyalgia 10 years after infection with Giardia lamblia: a controlled prospective cohort study.Scand J Pain. 2021 Oct 21;22(2):348-355. doi: 10.1515/sjpain-2021-0122. Print 2022 Apr 26. Scand J Pain. 2021. PMID: 34679267
-
Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study.BMC Gastroenterol. 2015 Nov 19;15:164. doi: 10.1186/s12876-015-0393-0. BMC Gastroenterol. 2015. PMID: 26585714 Free PMC article.
-
[Parasitosis and irritable bowel syndrome].Rev Chilena Infectol. 2016 Jun;33(3):268-74. doi: 10.4067/S0716-10182016000300003. Rev Chilena Infectol. 2016. PMID: 27598274 Review. Spanish.
Cited by
-
Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey.PLoS One. 2010 Nov 18;5(11):e15484. doi: 10.1371/journal.pone.0015484. PLoS One. 2010. PMID: 21124983 Free PMC article.
-
First multilocus sequence typing (MLST) of Giardia duodenalis isolates from humans in Romania.Parasit Vectors. 2020 Jul 31;13(1):387. doi: 10.1186/s13071-020-04248-2. Parasit Vectors. 2020. PMID: 32736595 Free PMC article.
-
Causal inference regarding infectious aetiology of chronic conditions: a systematic review.PLoS One. 2013 Jul 25;8(7):e68861. doi: 10.1371/journal.pone.0068861. Print 2013. PLoS One. 2013. PMID: 23935899 Free PMC article.
-
Development of functional gastrointestinal disorders after Giardia lamblia infection.BMC Gastroenterol. 2009 Apr 21;9:27. doi: 10.1186/1471-230X-9-27. BMC Gastroenterol. 2009. PMID: 19383162 Free PMC article.
-
Pomegranate Peel Extract Is a Potential Alternative Therapeutic for Giardiasis.Antibiotics (Basel). 2021 Jun 11;10(6):705. doi: 10.3390/antibiotics10060705. Antibiotics (Basel). 2021. PMID: 34208266 Free PMC article.
References
-
- Ortega YR, Adam RD. Giardia: overview and update. Clin Infect Dis. 1997;25:545–549; quiz 550. - PubMed
-
- Kucik CJ, Martin GL, Sortor BV. Common intestinal parasites. Am Fam Physician. 2004;69:1161–1168. - PubMed
-
- Hlavsa MC, Watson JC, Beach MJ. Giardiasis surveillance--United States, 1998-2002. MMWR Surveill Summ. 2005;54:9–16. - PubMed
-
- U.S. Food and Drug Administration. Giardia lamblia. In: The bad bug book foodborne pathogenic microorganisms and natural toxins handbook. Washington. 1992. Available from: www.cfsan.fda.gov/~mow/chap22.html.
-
- CDC Notifiable diseases/deaths in selected cities weekly information. Morbidity and Mortality Weekly Report. 2006;45:1320–1330.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical